Artelo Biosciences, Inc. (ARTL) earnings
Quarterly results of Artelo Biosciences, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Artelo Biosciences, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Artelo Biosciences, Inc. reported revenue of - and a net loss of $2.4M.
Diluted earnings per share were -$0.89.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$2.4M | -$0.89 |
| Q1 FY2026 | - | - | -$3M | -$4.00 |
| Q4 FY2025 | - | - | -$4.2M | - |
| Q3 FY2025 | - | - | -$3.1M | -$3.97 |
| Q2 FY2025 | - | - | -$3.2M | -$16.86 |
| Q1 FY2025 | - | - | -$2.4M | -$12.55 |
| Q4 FY2024 | - | - | -$3.8M | - |
| Q3 FY2024 | - | - | -$1.1M | -$2.10 |
Results filings
- Quarterly report (amended) 10-Q/A
- Quarterly report 10-Q
- Quarterly report 10-Q
When is Artelo Biosciences, Inc.'s next earnings date?
Artelo Biosciences, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Get an email when ARTL reports
Follow ARTL and we email you its next results the day they are filed, with the numbers explained.